Havrix 1440
Havrix 1440 is a medicine authorised by Swissmedic under authorisation number 558. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 September 1993 and the authorisation is valid without a time limit. ATC code J07BC02 places the medicine in the group Vaccines.
| Authorisation number | 558 |
|---|---|
| Name | Havrix 1440 |
| Full name | Havrix 1440, Injektionssuspension |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07BC02 |
| First authorisation | 03 September 1993 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Havrix 1440, Injektionssuspension | B | 03 September 1993 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Fertigspritze(n) | J07BC02 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Havrix 1440 authorised in Switzerland?
Yes. Havrix 1440 is authorised by Swissmedic under authorisation number 558, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Havrix 1440 have?
Havrix 1440 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Havrix 1440?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.